Tesla’s stock has found recent momentum from an unexpected source: a monumental semiconductor manufacturing project dubbed “Terafab.” The announcement of this planned facility, a joint venture with SpaceX in Austin with a price tag reaching $25 billion, pulled shares out of a three-day slump. However, it has also ignited a fierce debate among market analysts, centering on whether the electric vehicle maker can realistically transform into a chip producer while its core auto business continues to face significant headwinds.
The Terafab Vision: Unprecedented Scale
Unveiled by CEO Elon Musk on March 21, the Terafab initiative aims to construct two specialized chip fabrication plants. One would supply Tesla’s vehicles and its Optimus humanoid robots, while the other would focus on producing semiconductors for artificial intelligence data centers intended for space applications. Musk projects the facility will eventually deliver one terawatt of annual computing power, a scale that would position it as the largest semiconductor factory on the planet.
The rationale, according to Musk, is one of necessity. He contends that existing suppliers, including TSMC, Micron, and Samsung, would be incapable of meeting the immense demand generated by Tesla’s ambitious AI roadmap. His statement was unequivocal: “We build Terafab, or we have no chips.”
A Hefty Price Tag Divides Wall Street
The financial implications are substantial. The estimated $20 to $25 billion cost for Terafab comes on top of Tesla’s existing capital expenditure guidance, which already exceeds $20 billion for 2026. CFO Vaibhav Taneja confirmed that the Terafab expenses are not included in that current outlook. This projected outlay stands in stark contrast to the company’s reported free cash flow of $6.2 billion for 2025.
This disparity has led to a spectrum of reactions from financial experts:
- Wedbush Securities (Outperform rating, $600 price target) interprets Terafab as a potential precursor to a merger between Tesla and SpaceX by 2027.
- Baird (Buy rating, $548 target) views the project as a logical extension of Tesla’s established strategy of vertical integration within its supply chain.
- Barclays (Equalweight rating, $360 target) highlights capital risk, with analyst Dan Levy estimating the long-term total investment could surpass $100 billion.
- Morgan Stanley analysts project that building meaningful chip capacity alone would require an investment of $35 to $45 billion.
Observers, including Bloomberg, have noted that Musk lacks direct experience in semiconductor manufacturing and that critical details—such as the final timeline, exact locations, and precise cost breakdown—remain undisclosed.
European Vehicle Data Offers a Cautious Signal
Amidst the semiconductor discussion, recent vehicle registration data from Europe presented a nuanced picture. In February, Tesla’s new registrations increased by 11.8% year-over-year, marking the first positive month after 13 consecutive months of decline. However, Chinese automaker BYD registered 15,438 vehicles in the EU during the same period, surpassing Tesla’s 15,438 units and achieving a staggering growth rate of 185%.
Analysts caution against over-optimism, pointing out that the year-ago comparison period was exceptionally weak. In early 2025, Tesla had temporarily idled production lines at its Berlin, Shanghai, and other factories to retool for the updated “Juniper” Model Y.
The Upcoming Quarterly Test
All eyes are now on Tesla’s first-quarter 2026 results, scheduled for release on April 28. Analysts at UBS anticipate deliveries of approximately 345,000 vehicles, which would represent an 18% decline compared to the same quarter last year. Tesla’s stock has depreciated by roughly 11% since the start of the year, trading notably below its 50-day moving average. Whether the enthusiasm for Terafab can sustain the equity will also depend on regulatory developments concerning the company’s Full Self-Driving (FSD) system.
